ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000

Want To Know What Cancer Research Projects Are Going On? CRESPAC Can Describe More Than 5,000

January 2, 1976